Title : A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).

Pub. Date : 2008 Feb 26

PMID : 18253119






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 There are data suggesting that inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase signalling may reverse resistance to fluoropyrimidine treatment. 2-fluoropyrimidine epidermal growth factor receptor Homo sapiens
2 There are data suggesting that inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase signalling may reverse resistance to fluoropyrimidine treatment. 2-fluoropyrimidine epidermal growth factor receptor Homo sapiens